These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4467458)

  • 1. [Long-term medicinal prevention in patients who have suffered myocardial infarction].
    Doĭchinov A; Buchvarova B
    Vutr Boles; 1974; 13(5):24-9. PubMed ID: 4467458
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of myocardial infarction by chemotherapy].
    Toshima H; Adachi K
    Nihon Rinsho; 1982; 40(11):2465-70. PubMed ID: 6130172
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1983 Apr; 127(16):673-9. PubMed ID: 6134240
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary prevention following myocardial infarction--results of long-term studies].
    Berndt H
    Z Arztl Fortbild (Jena); 1983; 77(2):52-8. PubMed ID: 6132502
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy as secondary prevention following myocardial infarction].
    Cottier C
    Praxis (Bern 1994); 1996 Apr; 85(17):545-7. PubMed ID: 8668892
    [No Abstract]   [Full Text] [Related]  

  • 6. [Benefit and risks of prolonged continued anticoagulant treatment in patients who have experienced a transmural heart infarct].
    Loeliger EA; Tijssen J; Wintzen AR; de Vries WA; Roos J
    Ned Tijdschr Geneeskd; 1983 Mar; 127(10):428-33. PubMed ID: 6339956
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial infarction--secondary prevention.
    Hjalmarson A
    Acta Med Scand Suppl; 1986; 712():35-9. PubMed ID: 2880462
    [No Abstract]   [Full Text] [Related]  

  • 8. [Secondary prevention of myocardial infarction using anti-arrhythmia agents and beta-receptor blockers].
    Mösslacher H
    Acta Med Austriaca; 1984; 11(1):1-8. PubMed ID: 6143463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long term prophylaxis of re-infarct. Results of the persantin-acetylsalicylic acid re-infarct study].
    Fortschr Med; 1980 Aug; 98(32):1227-8. PubMed ID: 7409723
    [No Abstract]   [Full Text] [Related]  

  • 10. [Secondary prevention with drugs].
    Burkart F
    Schweiz Rundsch Med Prax; 1986 Jan; 75(4):57-60. PubMed ID: 2869563
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention and treatment of recurrences of myocardial infarction. Results in 2026 patients monitored for 44 months in a group study].
    Sem Hop; 1980 Oct 18-25; 56(39-40):1575-7. PubMed ID: 6255571
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary prevention of myocardial infarction with drugs.
    Klimt CR; Forman SA
    Isr J Med Sci; 1983 May; 19(5):460-70. PubMed ID: 6134697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocardial reinfarction. Considerations on secondary prevention].
    Mazza F; Messore T; Contiello V; Ciappa G; Caropreso MR; Petrillo T; Ucciero R
    Minerva Cardioangiol; 1985 Jun; 33(6):325-8. PubMed ID: 2864662
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of myocardial reinfarction. Recommendations based on results of drug trials.
    Flaker GC; Singh VN
    Postgrad Med; 1993 Nov; 94(6):94-8, 102-4. PubMed ID: 7901845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lasting anticoagulant prevention following myocardial infarct].
    Remde W
    Z Gesamte Inn Med; 1968 Mar; 23(6):85-8. PubMed ID: 5727299
    [No Abstract]   [Full Text] [Related]  

  • 16. [Complementary therapies in congestive circulatory insufficiency].
    Gaglio M; Caruso G; Centamore G; Di Fazzio S; Martello G; Milone A; Mazzone O; Trovato GM; Vancheri FS
    Boll Soc Ital Cardiol; 1979; 24(5):515-37. PubMed ID: 45252
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary prevention after myocardial infarction].
    Czuriga I
    Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of high risk patients after an acute myocardial infarction. Therapeutic approach for secondary prevention.
    Ribeiro LG; Kasdin SL
    Arq Bras Cardiol; 1985 Mar; 44(3):207-12. PubMed ID: 2868706
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
    Bousser MG
    J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
    Herlitz J; Holm J; Peterson M; Karlson BW; Haglid Evander M; Erhardt L;
    Eur Heart J; 2004 Feb; 25(3):232-9. PubMed ID: 14972424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.